Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
about
Self management for patients with chronic obstructive pulmonary diseaseComorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic ReviewCOPD and exercise: does it make a difference?Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspectiveDual therapy strategies for COPD: the scientific rationale for LAMA + LABACOPD: the patient perspectiveCOPD and its comorbidities: Impact, measurement and mechanismsComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementUnderrecognized comorbidities of chronic obstructive pulmonary diseaseMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseAgeing and the epidemiology of multimorbidityPredictive medicine: outcomes, challenges and opportunities in the Synergy-COPD projectVitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of AgeingPulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?Influence of a 10-Day Mimic of Our Ancient Lifestyle on Anthropometrics and Parameters of Metabolism and Inflammation: The "Study of Origin"Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD.Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?Living With Chronic Lower Pulmonary Disease: Disruptions of the Embodied Phenomenological Self.The COgnitive-Pulmonary Disease (COgnitive-PD) study: protocol of a longitudinal observational comparative study on neuropsychological functioning of patients with COPDDerivation and validation of clinical phenotypes for COPD: a systematic review.Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.Determination of Pain Phenotypes in Knee Osteoarthritis: A Latent Class Analysis Using Data From the Osteoarthritis Initiative.Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis.From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.Cytokine inhibition in the treatment of COPD.A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotypeRisk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysisA randomized clinical trial to assess the influence of a three months training program (gym-based individualized vs. calisthenics-based non-invidualized) in COPD-patients.Red cell distribution width is associated with long-term prognosis in patients with stable coronary artery disease.Is periodontitis a comorbidity of COPD or can associations be explained by shared risk factors/behaviors?Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort studySubtypes of patients experiencing exacerbations of COPD and associations with outcomes.Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patientsIntegrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations.Epidemiology and clinical impact of major comorbidities in patients with COPD.The mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD Assessment Test in primary care.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.A simplified score to quantify comorbidity in COPD
P2860
Q24197903-984121ED-FE40-4681-A502-F67AB4F05B98Q24288655-1EF8FBBE-F435-416D-87AB-C9A491CCF331Q26740768-87D8ABD0-253D-43F6-A083-B19A909D2164Q26749418-76EF5215-B73E-4DDC-9388-9B866618FB2FQ26752988-2BAED739-3577-41B7-8000-D843A1392807Q26764894-39172147-996E-4156-BCC8-CFD2C1E545FBQ26786812-A605778A-4D4A-4A6F-BCD6-4A5821634ABDQ26799659-54BE8B1C-3C3F-49BC-B078-3892651FB52DQ26800282-A19ED75E-D4C7-4A43-A1AA-B8B774E32805Q27000043-269BE831-E030-44A3-A918-6E7BBD81B7E9Q27012096-9EDEA4F4-34B5-4908-AD6D-86889B5B9B88Q27014689-C7BB3361-A70F-43DA-8D72-83D323D7C589Q28397350-04D2C982-882B-4F84-A235-E3EA94B4913EQ28596796-CB6D384E-E3C9-4FED-92F3-F011DBE05BBAQ28829810-75CAC6B7-7563-44BD-990E-C81F6836F920Q30248639-1D71A3FA-C971-4C77-8C39-3E99567360C6Q30251588-DE8D1F29-89AF-43CC-B762-89C59CB598D3Q30401577-753F58FA-5F40-4C4D-846F-38453171AC5CQ30573818-2692F8B0-F279-4054-BE3F-E64BA25028C3Q30653887-35080485-42E2-4522-BF72-30B5A59E64F5Q30989356-98EBD70C-D065-414F-B662-D1A10C411AEFQ30998667-0A5874E8-12B5-47C0-942A-2BAC38973C45Q31130054-2B8F56A1-31F6-4BE9-9814-8C60AF05D406Q31160925-5D7E8D55-7862-4441-8A8C-6A953ED8F181Q33568552-9DC00DC3-2B6E-4FBE-94F9-177A04D65054Q33588471-D8F814AB-972C-42BD-8B73-A69805C181C7Q33604883-45CCF006-B4F8-4622-AA08-6E9B460F1C34Q33612156-A7ADE2BA-2BB8-464B-8F2D-BBCCA1D6FC84Q33641597-4647FAA1-3445-43AD-AC73-CF90CDCDB4BEQ33649907-47CA4D92-9A0C-4E78-B3D1-00E806A73E37Q33704896-2311FA50-143A-45D1-8A63-ECEED660496BQ33707570-2C6A23A5-A386-4F6E-B9D1-AAFF245DB0DEQ33732176-54E4743F-146E-4085-B10C-D3C8B86C81CAQ33820309-CC9E7306-EF6D-4EDF-ACDC-48819B36F12EQ34134841-BD737C83-2339-4EB4-8F47-094C1012444DQ34352974-BDD466B7-FB29-4496-A314-44ADF50D21CBQ34511113-995C3606-09C8-42E2-8106-05CB5EF1E1B7Q34550471-F4DD61DB-6BA0-44EE-AEAB-58BA718BC9F2Q34636461-FDC3BBF9-66D4-4F58-B935-3B5760E8C3A2Q34712570-345A0358-91D9-4179-B80F-07F03A8BF8EA
P2860
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Clusters of comorbidities base ...... obstructive pulmonary disease.
@en
Clusters of comorbidities base ...... obstructive pulmonary disease.
@nl
type
label
Clusters of comorbidities base ...... obstructive pulmonary disease.
@en
Clusters of comorbidities base ...... obstructive pulmonary disease.
@nl
prefLabel
Clusters of comorbidities base ...... obstructive pulmonary disease.
@en
Clusters of comorbidities base ...... obstructive pulmonary disease.
@nl
P2093
P2860
P50
P1476
Clusters of comorbidities base ...... obstructive pulmonary disease.
@en
P2093
Erica P A Rutten
Jos Op 't Roodt
Lowie E G W Vanfleteren
Miriam Groenen
Piet L B Bruijnzeel
Swetlana Gaffron
Vanessa P M van Empel
P2860
P304
P356
10.1164/RCCM.201209-1665OC
P407
P577
2013-04-01T00:00:00Z